Table 1 Patient characteristics
No. of patients | Cycles of induction chemotherapy | Site of primary tumor | Positive lymph node station* | Stage |
|---|---|---|---|---|
1 | 1 | Left lower lobe | 4 L,4R, 10 L | T3N3 |
2 | 1 | Right middle lobe | 2R, 4R, 10R | T2N2 |
3 | 1 | Right upper lobe | 3P, 4 L, 4R, 7, 10R | T3N3 |
4 | 1 | Right lower lobe | 4R, 7, 8, 10R | T3N2 |
5 | 1 | Left upper lobe | 2 L, 3A, 4 L, 5, 7, 10 L | T2N2 |
6 | 1 | Right lower lobe | 7, 10R | T3N2 |
7 | 1 | Right upper lobe | 1, 2R, 4 L, 4R, 7, 10R | T3N3 |
8 | 1 | Left upper lobe | 4 L, 5, 10 L | T2N2 |
9 | 1 | Left hilus | 2 L, 2R, 3A, 4 L, 4R, 5, 6, 7, 8, 10 L | T3N3 |
10 | 1 | Left upper lobe | 3A, 4 L, 4R, 5, 6, 7, 10 L | T2N3 |
11 | 2 | Right lower lobe | 4R, 7, 10R | T2N2 |
12 | 2 | Right upper lobe | 2R, 4R, 7, 10R | T4N2 |
13 | 2 | Left upper lobe | 4 L, 6, 7, 10 L | T3N2 |
14 | 2 | Left upper lobe | 4 L, 4R, 5, 6, 10 L | T4N3 |
15 | 2 | Right hilus | 4R, 10R | T3N2 |
16 | 2 | Left upper lobe | 2 L, 4 L, 4R, 5, 6, 7, 10 L | T3N3 |
17 | 2 | Left lower lobe | 2R, 4R, 4 L, 6, 7, 8, 10 L | T3N3 |
18 | 2 | Left upper lobe | 1, 2 L, 3A, 6, 10 L | T2N3 |
19 | 2 | Right hilus | 3A, 4R, 10R | T3N2 |
20 | 2 | Left upper lobe | 2R, 4 L, 5, 6, 10 L | T3N3 |